Aggressive acid control: Minimizing progression of Barrett's esophagus

American Journal of Managed Care

Volumn 7, Issue 1 SUPPL., 2001, Pages

  Castell, D O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; VILLIN;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CANCER RISK; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE CONTROL; DISEASE COURSE; DOSE RESPONSE; DYSPLASIA; ESOPHAGUS CANCER; ESOPHAGUS PH; EXPOSURE; GASTROESOPHAGEAL REFLUX; HUMAN; MONITORING; PRIORITY JOURNAL; STOMACH ACID; STOMACH ACID SECRETION; STOMACH PH; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; BARRETT ESOPHAGUS; ENZYME INHIBITORS; GASTROESOPHAGEAL REFLUX; HUMANS; OMEPRAZOLE;

EID: 0035109867     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
2. Barrett's esophagus: Development of dysplasia and adenocarcinoma
3. Esophageal acid sensitivity in Barrett's esophagus
4. Successful elimination of reflux symptoms does not insure adequate control of acid reflux in patients with Barrett's esophagus
5. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow up
6. Dynamic effects of acid on Barrett's esophagus. An ex vivo proliferation and differentiation model
7. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression
8. Endoscopic regression of Barrett's oesophagus during omeprazole treatment: A randomised double blind study
9. Effect of maximal acid reflux control on Barrett's esophagus